Lygenesis 2017 Business Update Regenerative Medicine

Clinical-stage regenerative medicine company presenting 2016 financial results and 2017 strategic transformation. Focuses on development of implant products, bioreactors, and scaffolds for esophagus and airway applications with $8.0 million in funding closed February 2017.